Found 4 matching trials
Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC PHASE2 This will be the first prospective study where patients will be selected on...
Show More Location
Central Hematology Oncology Medical Group Inc.
Learn More & Join Trial
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer PHASE3 This 2 arm study will compare the efficacy and safety of sequential treatme...
Show More Location
Multiple Locations
Learn More & Join Trial
Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer PHASE4 Objective: To compare the efficacy and safety of chemotherapy plus intercal...
Show More Learn More & Join Trial
Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation PHASE2 This is a single arm phase II clinical trial, which aims to evaluate the ef...
Show More Location
Guangdong General Hospital & Guangdong Academy of Medical Sciences
Learn More & Join Trial